Levothyroxine Sodium Tablet
Product Images NDC 72789-297

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 72789-297). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (72789297)

Image (72789297)
Label for Levothyroxine Sodium USP 100 mcg oral tablets, 30 count, labeled by PD-Rx Pharmaceuticals, Inc. The label includes the NDC number 72789-297-30, lot number A23B20, and expiration date 05/2025. It features dosage instructions, warnings to keep out of reach of children, and contact information for reporting side effects to the FDA.*
FDA Label Image

Description (Levothyroxine Str)

Description (Levothyroxine Str)
Chemical structure diagram of Levothyroxine Sodium showing its molecular components, including iodine atoms, phenolic groups, and a carboxylate group with sodium and water molecules.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.